By Vijay Kumar Malesu In an interim analysis of an ongoing global trial, semaglutide resolved steatohepatitis in 63% of ...

Thank you for joining us today for the Dr. Reddy's earnings conference call covering the quarter and full year ended March 31, 2025. We appreciate your time and participation. Joining us today is the ...

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Rybelsus. Rybelsus is an oral form of semaglutide. It’s FDA-approved for diabetes, but (like Ozempic) it’s sometimes prescribed off-label for weight loss. Compounded semaglutide. Compounded ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25 mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review ...

The Danish drugmaker – which has its U.S. headquarters in Plainsboro – seeks regulatory approval for a once-a-day 25 milligram pill form of the semaglutide for chronic weight management ...

ONE GRAND PRIX THIS WEEKEND. FIVE ON YOUR HEALTH TONIGHT. SEVERE SIDE EFFECTS FROM SEMAGLUTIDE, A NATIONAL STUDY FINDS THEY SENT NEARLY 25,000 PEOPLE TO THE ER FOR TREATMENT. JOINING US NOW IS ...

The data will further extend the wide-ranging evidence base for semaglutide through real-world evidence studies and additional analysis of the landmark cardiovascular outcomes trial, SELECT, as well ...

Hims’ business got a boost when branded weight-loss drugs were in short supply and a regulatory loophole allowed it to sell less expensive compounded versions of drugs like semaglutide ...

The data will further extend the wide-ranging evidence base for semaglutide through real-world evidence studies and additional analysis of the landmark cardiovascular outcomes trial, SELECT ...